Lobbying

Global Alzheimer's Platform Innovations PBC's latest lobbying report covers Q4 2023, at $24K. Its first report covers Q4 2022; the issues it reports most are Medical/Disease Research/Clinical Labs and Medicare/Medicaid.

Global Alzheimer's Platform Innovations PBC

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Global Alzheimer's Platform Innovations PBC lobbying by quarter
Global Alzheimer's Platform Innovations PBC lobbying by quarter
QuarterAmountReports
Q4 2022$24K1
Q1 2023$24K1
Q2 2023$24K1
Q3 2023$24K1
Q4 2023$24K1
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Medical research and clinical labs$52K · 5 reports
  • Medicare and Medicaid$52K · 5 reports
  • Budget and appropriations$16K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES5 reports
  • SENATE5 reports

Firms it paid

Firm
Twenty-First Century Group$120K5 quarters

Former officials lobbying for it

Former position
JACK FIELDSFormer Member of CongressQ4 2023
LISA D RULLIFormer staffer, Committee on Merchant Marine & Fisheries; Committee on Natural Resources.Q4 2023

Lobbying reports

Filed by
24/01/17for Q4 2023Twenty-First Century Group$24K
23/10/17for Q3 2023Twenty-First Century Group$24K
23/07/19for Q2 2023Twenty-First Century Group$24K
23/04/18for Q1 2023Twenty-First Century Group$24K
23/01/19for Q4 2022Twenty-First Century Group$24K